Axogen, Inc. (AXGN)
NASDAQ
Closed
Oct 7, 2026
Day's Range
35.8352 wk Range
15.27Overview - AXGN - Axogen, Inc.
Key Statistics
Valuation
Enterprise Value
2.23B
P/E (Trailing)
‪-127.38‬
P/E (Forward)
‪63.24‬
PEG Ratio
‪0.31‬
Price / Sales (TTM)
‪10.11‬
Price / Book
‪9.07‬
EV / EBITDA
‪-374.93‬
Profitability
Gross Margin
‪72.67%‬
Profit Margin
‪-13.35%‬
Operating Margin
‪-3.09%‬
Return on Assets
‪-3.14%‬
Return on Equity
‪-18.20%‬
Ownership
Shares Outstanding
53.17M
Float
52.71M
Short % of Shares Outstanding
‪8.18%‬
Held by Insiders
‪1.98%‬
Held by Institutions
‪90.93%‬
Price stats
Beta
‪1.16‬
50-Day Avg
‪45.47‬
200-Day Avg
‪38.56‬
Dividends
Payout Ratio
‪0.00%‬
Analyst Consensus
10 analysts
Average price target
‪$ 53.90‬Shariah Compliance
Report Date: Feb 15, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - AXGN - Axogen, Inc.
Peers - AXGN - Axogen, Inc.
Peer Comparison
Compared with companies in Medical Devices listed on NASDAQ.
- AXGNNASDAQAxogen, Inc.2.54BMarket Cap+60.94%52-week change-127.38P/E (Trailing)‪-13.35%‬Profit Margin
- DXCMNASDAQDexCom Inc.32.21BMarket Cap+22.26%52-week change33.74P/E (Trailing)‪20.11%‬Profit Margin
- GEHCNASDAQGE HealthCare Technologies Inc.29.24BMarket Cap-18.85%52-week change14.81P/E (Trailing)‪9.33%‬Profit Margin
- BRKRNASDAQBruker Corp.9.63BMarket Cap+42.35%52-week change74.88P/E (Trailing)‪-2.03%‬Profit Margin
- TLTLTNASDAQiShares 20+ Year Treasury Bond ETF9.46BMarket Cap-14.44%52-week change—P/E (Trailing)—Profit Margin
- PODDNASDAQInsulet Corporation9.13BMarket Cap-136.69%52-week change24.66P/E (Trailing)‪12.29%‬Profit Margin
- LIVNNASDAQLivaNova PLC4.13BMarket Cap+29.89%52-week change22.01P/E (Trailing)‪12.81%‬Profit Margin
Profile Summary - AXGN - Axogen, Inc.
About
Axogen, Inc. is a medical technology company focused on peripheral nerve regeneration and repair. Axogen develops and commercializes surgical solutions used by surgeons and healthcare providers to address nerve injuries caused by trauma, procedures, or disease. Its current product portfolio includes nerve allografts,…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
